TEACHERS ADVISORS, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2019$1,189,000
+28.3%
319,5070.0%0.00%0.0%
Q4 2018$927,000
-40.0%
319,507
-45.6%
0.00%0.0%
Q3 2018$1,544,000
+122.2%
587,288
+97.8%
0.00%0.0%
Q2 2018$695,000
-20.4%
296,9680.0%0.00%0.0%
Q1 2018$873,000
+7.2%
296,9680.0%0.00%0.0%
Q4 2017$814,000
-19.2%
296,9680.0%0.00%0.0%
Q3 2017$1,007,000
+34.8%
296,968
-1.8%
0.00%0.0%
Q2 2017$747,000
+5.7%
302,345
-3.0%
0.00%0.0%
Q1 2017$707,000
+11.3%
311,539
+3.9%
0.00%0.0%
Q4 2016$635,000
-25.9%
299,746
+17.2%
0.00%0.0%
Q3 2016$857,000
+6.7%
255,8240.0%0.00%0.0%
Q2 2016$803,000
-2.1%
255,824
+3.9%
0.00%0.0%
Q1 2016$820,000
-6.0%
246,2390.0%0.00%
-50.0%
Q4 2015$872,000
-29.6%
246,2390.0%0.00%0.0%
Q3 2015$1,239,000
-21.7%
246,2390.0%0.00%
-33.3%
Q2 2015$1,583,000
-7.5%
246,239
+1.3%
0.00%0.0%
Q1 2015$1,711,000
-0.7%
243,183
+8.8%
0.00%0.0%
Q4 2014$1,723,000
+1.6%
223,427
-1.6%
0.00%0.0%
Q3 2014$1,696,000
-69.7%
227,078
-60.7%
0.00%
-72.7%
Q2 2014$5,593,000
-13.4%
577,829
-25.6%
0.01%
-21.4%
Q1 2014$6,456,000
+1.4%
776,922
+3.0%
0.01%0.0%
Q4 2013$6,367,000
+239.9%
754,411
+221.0%
0.01%
+180.0%
Q3 2013$1,873,000
+6.2%
235,051
+2.9%
0.01%0.0%
Q2 2013$1,763,000228,3940.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,585,500$3,710,0001.36%
SMH CAPITAL ADVISORS INC 83,369$195,0000.32%
West Family Investments, Inc. 338,141$791,0000.20%
Matarin Capital Management, LLC 927,289$2,169,856,0000.16%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$33,0000.12%
Alambic Investment Management, L.P. 163,200$382,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 1,760,376$4,119,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 5,677,647$13,286,0000.08%
Zebra Capital Management LLC 67,892$159,0000.07%
Fortis Advisors, LLC 45,602$107,0000.06%
View complete list of PDL BIOPHARMA INC shareholders